Positive correlation between apoptotic and proliferative indices in gastrointestinal lymphomas of mucosa-associated lymphoid tissue (MALT)

Journal of Pathology

Volumn 178, Issue 4, 1996, Pages 379-384

  Du, Mingqing ^a   Singh, Nalini ^a   Husseuin, Aziz ^b   Isaacson, Peter G ^a   Pan, Langxing ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

Apoptosis; bcl 2; Cell proliferation; MALT lymphomas

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL;

APOPTOSIS; CELL DIVISION; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029979366     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199604)178:4<379::AID-PATH487>3.0.CO;2-J     Document Type: Article

References (35)

1. Isaacson PG. gastrointestinal lymphoma Hum Pathol 1994, 25: 1020-1029.
2. Cogliatti SB, Schmid U, Schumacher U, et al Primary B-cell gastric lymphoma. clinicopathological study of 145 patients Gastroenterology 1991, 101: 1159-1170.
3. Hussell T, Isaacson PG, Spencer J. Proliferation and differentiation of tumour cells from B-cell lymphoma of mucosa-associated lymphoid tissue in vitro. J Pathol 1993; 169: 221-227.
4. Hussell T, Isaacson PG, Spencer J The response of cells from low grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylort. Lancet 1993; 342: 571-574.
5. Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobacter pylori-specific T cells provide cognate help for the proliferation of tumour B cells in gastric lymphoma. J Pathol 1995; 175: 113A.
6. Wotherspoon AC, Doglioni C, Diss T, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
7. McCarthy NJ, Smith CA, Williams GJ Apoptosis in the development of immune system: growth factors, clonal selection and bcl-2. Cancer Met Rev 1992; 11: 157-178.
8. Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res 1990, 10: 1153-1160
9. Wyllie AH. Apoptosis and regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Met Rev 1992; 11: 95-103.
10. Sarraf CE, Bowen ID Proportions of mitotic and apoptotic cells in a range of untreated experimental tumours. Cell Tissue Kinet 1988; 21: 45-49.
11. Del Vecchio MT, Leoncini L, Buerki K, et al. Diffuse centrocytic and/or centroblastic malignant non-Hodgkin's lymphomas. comparison of mitotic and pyknotic (apoptotic) indices. Int J Cancer 1991; 47: 38-43.
12. Leoncini L, Del Vecchio MT, Megha T, et al Correlation between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 1993; 142: 755-763.
13. Hollowood K, MaCartney JC. Reduced apoptotic cell death in follicular lymphoma. J Pathol 1991; 163: 337-342.
14. Ansari B, Coates PJ, Greenstein BD, Hall PA In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states J Pathol 1993; 170: 1-8.
15. Norton AJ, Jordan S, Yeomans P. Brief high temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues J Pathol 1994; 173: 371-379.
16. Wyllie AH, Morris RG, Smith AL, Dunlop D Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
17. Coulton GR, Rogers B, Strutt P, Skynner MJ, Watt DJ. In situ localisation of single-stranded DNA breaks in nuclei of a subpopulation of cells within regenerating skeletal muscle of the dystrophic mdx mouse J Cell Sci 1992; 102: 653-662.
18. Oren M. The involvement of oncogenes and tumour suppressor genes in the control of apoptosis Cancer Met Rev 1992; 11: 141-148.
19. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C elegans cell death gene ced-3. Cell 1993; 75: 653-660
20. McDonnell TJ, Deane N, Platt FM, et al. bcl-2 immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation Cell 1989; 57: 79-88.
21. Borzillo GV, Endo K, Tsujimoto Y bcl-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture. Oncogene 1992, 7: 869-876
22. Bissonnette RP, Echeverri F, Mahboubi A, Green DR Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992, 7: 869-876
23. Miyashita T, Reed JC. bcl-2 gene transfer increases resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs Cancer Res 1992; 52: 5407-5411
24. Hockenbery D, Zutter M, Hichey W, Nahm M, Korsmeyer SJ. bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991, 88: 6961-6965.
25. Evan GI, Littlewood TD. The role of c-myc in cell growth Curr Opin Gen Dev 1993; 3: 44-49.
26. van Krieken JHJM, Raffeld M, Raghoebier S, et al. Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. Blood 1990; 76: 797-800
27. Kastan MB, Onyinye O, Sydransky D, Vogelstein B, Craig R Participation of p53 in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-6311.
28. Lane DP p53, guardian of the genome. Nature 1992; 358: 15-16.
29. Marx J. Cell death studies yield cancer clues Science 1993; 259: 760-761.
30. Bártek J, Bártková J, Vojtések B, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 1991; 6: 1699-1703.
31. Ridgway PJ, Hale TK, Braithwaite AW. p53 confers a selective advantage on transfected Hela cells. Oncogene 1993; 8: 1069-1074.
32. Dittmer D, Pati S, Zambetti G, et al. Gain of function mutations in p53 Nature Genet 1993; 4: 42-46
33. El Rouby S, Thomas A, Costin D, et al p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood 1993, 82: 3452-3459.
34. Shi L, Kam CM, Powers JC, Aebersold R, Greenberg AH Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 1992; 176: 1521-1529
35. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994; 76: 777-779.